Advertisement

Protective effect of AA-861 (5-lipoxygenase inhibitor) on experimental acute necrotizing pancreatitis in rats

  • Masato Kiriyama
  • Ryohei Izumi
  • Itsuo Miyazaki
Article
  • 10 Downloads

Summary

The effect of the 5-lipoxygenase inhibitor AA-861 on acute necrotizing pancreatitis was studied in an experimental model. Pancreatitis was induced in rats by retrograde injection of 0.4 mL/kg body wt of 6% taurocholic acid into the pancreatic duct. The animals were divided into three groups: control group; administered AA-861 in a single dose of 30 mg/kg; and administered AA-861 in a single dose of 60 mg/kg. The following parameters were examined: serum amylase, lipase, trypsin, blood sugar, and survival rate. Histology of the pancreas was also studied. The serum amylase and lipase activities in groups 2 and 3 were lower than those in group 1 in the early phase after induction of pancreatitis. The elevation of serum trypsin was not suppressed by AA-861. Blood sugar was more efficiently controlled in groups 2 and 3 than in group 1. The survival rates in groups 2 and 3 were better than that in group 1, but there were no significant differences among the three groups. Histologically, massive tissue necrosis with hemorrhage, edema, and inflammatory cell infiltration was prominent in group 1, whereas such changes were obviously suppressed in groups 2 and 3. The results suggest that AA-861 may prove useful in the treatment of acute pancreatitis.

Key words

5-lipoxygenase AA-861 acute necrotizing pancreatitis 

References

  1. 1.
    van Ooijen B, Kort WJ, Zijlstra FJ, Vincent JE, Wilson JHP, Westbroek DL. Prostanoid imbalance in experimental acute necrotizing pancreatitis in rats.Scand J Gastroenterol 1988; 23: 193–198.PubMedCrossRefGoogle Scholar
  2. 2.
    van Ooijen B, Ouwendijk RJT, Kort WJ, Zijlstra FJ, Vincent JE, Wilson JHP, Westbroek DL. Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, daxoxiben, and indomethacin.Scand J Gastroenterol 1988; 23: 188–192.PubMedCrossRefGoogle Scholar
  3. 3.
    Kiviniemi H, Ramo J, Stahlberg M, Laitinen S, Jalovaara P, Viinikka L, Kairaluoma M. Prostacyclin and thromboxane in acute hemorrhagic pancreatitis in dogs.J Surg Res 1987; 42: 232–236.PubMedCrossRefGoogle Scholar
  4. 4.
    Williams KI, Higgs GA. Eicosanoids and inflammation.J Pathology 1988; 156: 101–110.CrossRefGoogle Scholar
  5. 5.
    Goldberg RN, Suguihara C, Streitfeld MM, Bancalari A, Clark MR, Bancalari E. Effects of a leukotriene antagonist, on the early hemodynamic manifestations of group B streptococcal sepsis in piglets.Pediatric Res 1986; 20: 1004–1008.CrossRefGoogle Scholar
  6. 6.
    Keppler D; Huber M, Baumert T. Leukotrienes as mediators in disease of the liver.Seminars in Liver Dis 1988; 8: 357–366.CrossRefGoogle Scholar
  7. 7.
    Brom J, Koller M, Schonfeld W, Knoller J, Erbs G, Muller FE, Konig W. Decreased expression of leukotriene B4 receptor sites on polymorphonuclear granulocytes of severely burned patients.Prostaglandins Leukotrienes and Essential Fatty Acids 1988; 34: 153–159.CrossRefGoogle Scholar
  8. 8.
    Tsai JJ, Cromwell O, Maestrelli P, O’Hehir RE, Moqbel R, Kay AB. Leukotriene release enhancing factor. ’ Purification, specific allergen induction, and further biologic properties.J Immunology 1989; 142: 1661–1668.Google Scholar
  9. 9.
    Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.J Allergy Clin Immunol 1989; 83: 450–455.PubMedCrossRefGoogle Scholar
  10. 10.
    Makovec F, Bani M, Cereda R, Chiste R, Revel L, Rovati LC, Setnikar I, Rovati LA. Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice.Peptides 1986; 7: 1159–1164.PubMedCrossRefGoogle Scholar
  11. 11.
    Lankisch PG, Pohl U, Goke B, Otto J, W-Siemiatkowska U, Grone HJ, Rahlf G. Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models.Gastroenterology 1989; 96: 193–199.PubMedGoogle Scholar
  12. 12.
    Wilson C, Imrie CW. Effective ip antiprotease therapy for taurocholate-induced pancreatitis in rats.Br J Surg 1990; 77: 1252–1255.PubMedCrossRefGoogle Scholar
  13. 13.
    Niederau C, Ferrell LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript and secretin.Gastroenterology 1985;88:1192–1204.PubMedGoogle Scholar
  14. 14.
    Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation?Int J Pancreatology 1988; 3: 105–112.Google Scholar
  15. 15.
    Tani S, Otuki M, Itoh H, Nakamura T, Fujii M, Okabayashi Y, Fujisawa T, Baba S. The protective effect of the trypsin inhibitor Urinastatin on cerulein-induced acute pancreatitis in rats.Pancreas 1988; 3: 471–476.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1993

Authors and Affiliations

  • Masato Kiriyama
    • 1
  • Ryohei Izumi
    • 1
  • Itsuo Miyazaki
    • 1
  1. 1.Second Department of Surgery, School of MedicineKanazawa UniversityKanazawaJapan

Personalised recommendations